414 related articles for article (PubMed ID: 31276749)
21. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
Candela P; Saint-Pol J; Kuntz M; Boucau MC; Lamartiniere Y; Gosselet F; Fenart L
Brain Res; 2015 Jan; 1594():15-26. PubMed ID: 25451130
[TBL] [Abstract][Full Text] [Related]
22. Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway.
Wani A; Al Rihani SB; Sharma A; Weadick B; Govindarajan R; Khan SU; Sharma PR; Dogra A; Nandi U; Reddy CN; Bharate SS; Singh G; Bharate SB; Vishwakarma RA; Kaddoumi A; Kumar A
Autophagy; 2021 Nov; 17(11):3813-3832. PubMed ID: 33404280
[TBL] [Abstract][Full Text] [Related]
23. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
24. Processing of endogenous AβPP in blood-brain barrier endothelial cells is modulated by liver-X receptor agonists and altered cellular cholesterol homeostasis.
Schweinzer C; Kober A; Lang I; Etschmaier K; Scholler M; Kresse A; Sattler W; Panzenboeck U
J Alzheimers Dis; 2011; 27(2):341-60. PubMed ID: 21811018
[TBL] [Abstract][Full Text] [Related]
25. Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer's disease: A potential therapeutic target?
Patel P; Shah J
J Chem Neuroanat; 2017 Nov; 85():36-42. PubMed ID: 28669880
[TBL] [Abstract][Full Text] [Related]
26. Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells.
Ito S; Ohtsuki S; Murata S; Katsukura Y; Suzuki H; Funaki M; Tachikawa M; Terasaki T
J Alzheimers Dis; 2014; 38(1):185-200. PubMed ID: 23948938
[TBL] [Abstract][Full Text] [Related]
27. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
28. Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.
Mohamed LA; Zhu H; Mousa YM; Wang E; Qiu WQ; Kaddoumi A
J Alzheimers Dis; 2017; 56(3):1087-1099. PubMed ID: 28059785
[TBL] [Abstract][Full Text] [Related]
29. Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.
Jeynes B; Provias J
Curr Alzheimer Res; 2008 Oct; 5(5):432-7. PubMed ID: 18855584
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells.
Wilhelmus MM; Otte-Höller I; van Triel JJ; Veerhuis R; Maat-Schieman ML; Bu G; de Waal RM; Verbeek MM
Am J Pathol; 2007 Dec; 171(6):1989-99. PubMed ID: 18055545
[TBL] [Abstract][Full Text] [Related]
31. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.
Qosa H; LeVine H; Keller JN; Kaddoumi A
Biochim Biophys Acta; 2014 Sep; 1842(9):1806-15. PubMed ID: 24997450
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
33. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
34. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
35. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.
Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870
[TBL] [Abstract][Full Text] [Related]
36. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.
Deane R; Sagare A; Hamm K; Parisi M; LaRue B; Guo H; Wu Z; Holtzman DM; Zlokovic BV
J Neurosci; 2005 Dec; 25(50):11495-503. PubMed ID: 16354907
[TBL] [Abstract][Full Text] [Related]
37. LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model.
Nazer B; Hong S; Selkoe DJ
Neurobiol Dis; 2008 Apr; 30(1):94-102. PubMed ID: 18289866
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
[TBL] [Abstract][Full Text] [Related]
39. Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
An Y; Qi Y; Li Y; Li Z; Yang C; Jia D
Neurosci Lett; 2022 Mar; 774():136528. PubMed ID: 35157973
[TBL] [Abstract][Full Text] [Related]
40. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
P X; Zz L; Gg J; Lp W; Cm B; Yl W; Chen MF; W L
Neurochem Int; 2022 Nov; 160():105417. PubMed ID: 36067928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
